PMID- 36633545 OWN - NLM STAT- MEDLINE DCOM- 20230313 LR - 20230313 IS - 1827-1839 (Electronic) IS - 0392-9590 (Linking) VI - 42 IP - 1 DP - 2023 Feb TI - Mills valvulotome reduces distal vein injuries and improves follow-up freedom from restenosis in patients undergoing infrainguinal in-situ saphenous vein bypass. PG - 19-25 LID - 10.23736/S0392-9590.22.04982-3 [doi] AB - BACKGROUND: In this study, the early and mid-term outcomes of the use of the Mills valvulotome in patients with chronic limb-threatening ischemia (CLTI) undergoing infrainguinal in-situ saphenous vein bypass were investigated. METHODS: From January 2018 until December 2019, 153 consecutive CLTI patients from 7 centers have been treated with infrainguinal in-situ saphenous vein bypass. In all patients the devalvulation of the great saphenous vein (GSV) was obtained with the use of the HYDRO LeMaitre((R)) valvulotome (LeMaitre Vascular, Burlington, MA, USA). Eighty-six patients (56.2%) received the additional treatment of the LeMills valvulotome (LeMaitre Vascular) to disrupt the distal valves of the GSV (Group MV), whilst in the remaining 67 patients (43.8%) this adjunctive device was not used (Group no-MV). Initial outcome measures including intraoperative vein injuries were assessed and compared. At 2-year follow-up, estimated outcomes of primary patency, primary assisted patency, secondary patency, freedom from distal vein restenosis, and limb salvage were analyzed using Kaplan-Meier curves and compared between groups using the log-rank test. RESULTS: Intraoperatively, the overall rate of vein injuries related to the devalvulation was 5.2% (8 cases) with four cases in both groups (4/86, 4.6%, Group MV vs. 4/67, 6%, Group no-MV; P=0.49). Overall, 4 lesions occurred in the distal portion of the GSV and were all reported in Group no-MV (0/86, 0%, Group MV vs. 4/67, 6%, Group no-MV; P=0.03). Median duration of follow-up was 12 months (IQR: 6-24). At 2-year follow-up there were no differences between the two groups in terms of primary patency (69.9% Group MV vs. 79.8% Group no-MV, P=0.08), primary assisted patency (85.4% Group MV vs. 90.5% Group no-MV, P=0.37), secondary patency (94.2% Group MV vs. 92.1% Group no-MV, P=0.61), and limb salvage (97.4% Group MV vs. 98.2% Group no-MV, P=0.74). Patients in Group MV had a higher rate of freedom from distal vein restenosis (92.2% Group MV vs. 76% Group no-MV, P=0.03). CONCLUSIONS: Adjunctive use of the Mills valvulotome (LeMaitre Vascular) reduces intraoperative distal vein injuries and improves the 2-year freedom from distal vein restenosis in patients undergoing infrainguinal in-situ saphenous vein bypass. FAU - Troisi, Nicola AU - Troisi N AD - Unit of Vascular Surgery, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy - nicola.troisi@unipi.it. FAU - Michelagnoli, Stefano AU - Michelagnoli S AD - Unit of Vascular and Endovascular Surgery, San Giovanni di Dio Hospital, Florence, Italy. FAU - Salvini, Mauro AU - Salvini M AD - Unit of Vascular Surgery, Ospedale Civile Santi Antonio e Biagio e Cesare Arrigo, Alessandria, Italy. FAU - DE Blasis, Giovanni AU - DE Blasis G AD - Unit of Vascular Surgery, Ospedale Santi Filippo e Nicola, Avezzano, L'Aquila, Italy. FAU - Ercolini, Leonardo AU - Ercolini L AD - Unit of Vascular Surgery, San Donato Hospital, Arezzo, Italy. FAU - Pratesi, Carlo AU - Pratesi C AD - Department of Vascular Surgery, University of Florence, Florence, Italy. FAU - Frosini, Pierfrancesco AU - Frosini P AD - Unit of Vascular Surgery, San Jacopo Hospital, Pistoia, Italy. FAU - Berchiolli, Raffaella AU - Berchiolli R AD - Unit of Vascular Surgery, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy. LA - eng PT - Journal Article DEP - 20230112 PL - Italy TA - Int Angiol JT - International angiology : a journal of the International Union of Angiology JID - 8402693 SB - IM MH - Humans MH - *Saphenous Vein/surgery MH - Vascular Patency MH - *Vascular Surgical Procedures MH - Femoral Vein MH - Limb Salvage MH - Treatment Outcome MH - Retrospective Studies MH - Ischemia/surgery MH - Risk Factors EDAT- 2023/01/13 06:00 MHDA- 2023/03/14 06:00 CRDT- 2023/01/12 10:16 PHST- 2023/01/13 06:00 [pubmed] PHST- 2023/03/14 06:00 [medline] PHST- 2023/01/12 10:16 [entrez] AID - S0392-9590.22.04982-3 [pii] AID - 10.23736/S0392-9590.22.04982-3 [doi] PST - ppublish SO - Int Angiol. 2023 Feb;42(1):19-25. doi: 10.23736/S0392-9590.22.04982-3. Epub 2023 Jan 12.